Suzhou Basecare Medical Corporation Limited Share Price

Equities

2170

CNE100004BC1

Healthcare Facilities & Services

Market Closed - Hong Kong S.E. 09:09:00 03/05/2024 BST 5-day change 1st Jan Change
2.31 HKD +5.96% Intraday chart for Suzhou Basecare Medical Corporation Limited +14.93% -1.70%

Financials

Sales 2024 * 459M 63.33M 495M 5.05B Sales 2025 * - Capitalization 585M 80.84M 631M 6.45B
Net income 2024 * -78M -10.77M -84.14M -859M Net income 2025 * - EV / Sales 2024 * 1.28 x
Net cash position 2024 * - 0 0 0 Net cash position 2025 * - 0 0 0 EV / Sales 2025 * -
P/E ratio 2024 *
-7.27 x
P/E ratio 2025 *
-
Employees 586
Yield 2024 *
-
Yield 2025 *
-
Free-Float 26.54%
More Fundamentals * Assessed data
Dynamic Chart
Suzhou Basecare Medical Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Suzhou Basecare Medical Corporation Limited Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Suzhou Basecare Medical Corporation Limited Announces Board Appointments CI
Suzhou Basecare Medical's Expects Gross Profit to Jump Up To 20.5% in First Half MT
Suzhou Basecare Medical Corporation Limited Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2023 CI
Suzhou Basecare Medical Corporation Limited Announces Executive Changes CI
Suzhou Basecare Completes $40 Million Acquisition of Singaporean Fertility Products Provider MT
Suzhou Basecare Medical Corporation Limited completed the acquisition of BMX Holdco Pte. Ltd. from individual investors and funds. CI
Suzhou Basecare Medical Corporation Limited Announces Resignation of Chau Kwok Keung Independent Non-Executive Director, Effect from June 14, 2023 CI
Suzhou Basecare Medical to Buy Entire Stake in Singapore-Based Fertility Products Provider MT
Suzhou Basecare Medical Corporation Limited entered into an agreement to acquire BMX Holdco Pte. Ltd. from individual investors and funds for approximately CNY 280 million. CI
Suzhou Basecare Medical Trims Loss in 2022 as Revenue Jumps 31% MT
Suzhou Basecare Medical Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Over a dozen Chinese-based firms say they have minimal exposure to SVB RE
Suzhou Basecare Medical Eyes Shanghai IPO MT
More news
1 day+5.96%
1 week+14.93%
Current month+8.45%
1 month+19.69%
3 months+8.45%
6 months-15.69%
Current year-1.70%
More quotes
1 week
1.98
Extreme 1.98
2.32
1 month
1.89
Extreme 1.89
2.32
Current year
1.83
Extreme 1.83
2.40
1 year
1.83
Extreme 1.83
4.81
3 years
1.83
Extreme 1.83
28.90
5 years
1.83
Extreme 1.83
34.85
10 years
1.83
Extreme 1.83
34.85
More quotes
Managers TitleAgeSince
Chief Executive Officer 44 13/12/10
Director of Finance/CFO 39 27/11/22
Chief Operating Officer 36 16/11/14
Members of the board TitleAgeSince
Director/Board Member 72 15/01/21
Chief Executive Officer 44 13/12/10
Chief Tech/Sci/R&D Officer 44 06/06/11
More insiders
Date Price Change Volume
03/05/24 2.31 +5.96% 95,000
02/05/24 2.18 +2.35% 115,000
30/04/24 2.13 -0.47% 1,000
29/04/24 2.14 +6.47% 188,000
26/04/24 2.01 +0.50% 31,500

Delayed Quote Hong Kong S.E., May 03, 2024 at 09:09 am

More quotes
Suzhou Basecare Medical Co Ltd, formerly Jiangsu Double Helix Biology Science and Technology Co Ltd, is a China-based investment holding company mainly engaged in the provision of assisted reproductive genetic testing solutions. The Company provides genetic testing solutions and sells genetic testing equipment and instruments. The genetic testing solutions include sales of testing kits and provision of testing services. The Company's main products include PGT-A kits. The Company mainly conducts business within the domestic market.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
2.14 CNY
Average target price
11.18 CNY
Spread / Average Target
+422.55%
Consensus

Annual profits - Rate of surprise